ASX Stock

At Trader Dealer we understand the importance of information. You can use our handy company information finder to get key fundamental data about any company listed on the ASX.

Simply enter the stock code or the name of the company you are interested in for ASX share price information, company size, research analyst forecast, share and financial ratios, as well as a business and financial summary.

Don’t know the ASX code of the stock you want? Just click on the letter below for a full alphabetical listing.


Enter ASX Stock Code

Bookmark Page !



View all Companies by Letters

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 


 
 

Acuvax Ltd.
Industry Group: Pharmaceuticals - Diversified - Pharmaceuticals - Diversified

Trade Online with Trader Dealer

Sorry, No Chart Available.

Business Summary
Acuvax Limited is an Australia-based holding company. The Company is engaged in the research and development of cancer therapies and virus and vaccine development. The Company is engaged in oncology drug research and development in two geographical segments: Australia and the United States. As of June 30, 2010, Acuvax had a 28% ownership in Hawaii Biotech Inc. (HBI). The principal activity of HBI is the development of preventative or prophylactic vaccines for infectious diseases, such as West Nile virus and dengue fever. The Company’s wholly owned subsidiaries include ACT (USA), Inc., Inqbate Pty Ltd and AL Holdings, Inc.

Financial Summary
BRIEF: For the Fiscal year ended 30 June 2011, Acuvax Limited's revenues decreased 95% to A$25K. Net loss decreased 67% to A$609K. Revenues reflects higher other income. Net loss reflects by an the absence of depreciation expenses, decrease in professional fees, decrease in employee and director expenses, decrease in travel expenses, decrease in office expenses and decrease in corporate expenses.

Business Address


320 Adelaide Street
BRISBANE, QLD 4000
Phone: 61-7-30109442
Fax: 61-7-30109001
http://www.acuvax.com.au/

ASX Share Price Information
Current Price 0.001
Current Price Date 17/02/2012
52 Week Hi/Low 0.00 - 0.00
Avg Volume Last ten Days 0.47
ASX Company Sizing
Market Cap 2.46
Revenues 1.43
EBITDA -0.61
Net Income -0.61
Number of Employees 0
Enterprise Value 1.43
Research Analyst Forecast
Consensus Recommendation -
Target Price -
LT Growth Rate -
Projected P/E -
Sales -
EPS -
Profit -
DPS -
Share Ratios
EPS -0.00049
RPS 0.00002
BV per Share 0.00055
Cash per Share 0.00059
Cashflow per Share -0.00049
Cashflow per Share 0.00000
Financial Ratios
Gross Margin -
ROE -178.69060
Price/Sales 100.08540
P/E -
P/Book 1.83335